Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-53079
Sci Rep January 1, 2017; 7 43173.

Nicotinic acid inhibits glioma invasion by facilitating Snail1 degradation.

Li J , Qu J , Shi Y , Perfetto M , Ping Z , Christian L , Niu H , Mei S , Zhang Q , Yang X , Wei S .


Abstract
Malignant glioma is a formidable disease that commonly leads to death, mainly due to the invasion of tumor cells into neighboring tissues. Therefore, inhibition of tumor cell invasion may provide an effective therapy for malignant glioma. Here we report that nicotinic acid (NA), an essential vitamin, inhibits glioma cell invasion in vitro and in vivo. Treatment of the U251 glioma cells with NA in vitro results in reduced invasion, which is accompanied by a loss of mesenchymal phenotype and an increase in cell-cell adhesion. At the molecular level, transcription of the adherens junction protein E-cadherin is upregulated, leading to accumulation of E-cadherin protein at the cell-cell boundary. This can be attributed to NA''s ability to facilitate the ubiquitination and degradation of Snail1, a transcription factor that represses E-cadherin expression. Similarly, NA transiently inhibits neural crest migration in Xenopus embryos in a Snail1-dependent manner, indicating that the mechanism of action for NA in cell migration is evolutionarily conserved. We further show that NA injection blocks the infiltration of tumor cells into the adjacent brain tissues and improves animal survival in a rat model of glioma. These results suggest that NA treatment may be developed into a potential therapy for malignant glioma.

PubMed ID: 28256591
PMC ID: PMC5335718
Article link: Sci Rep
Grant support: [+]

Species referenced: Xenopus
Genes referenced: actb myc snai1 snai2
Antibodies: Myc Ab8 actb Ab3


Article Images: [+] show captions
References [+] :
Appolloni, A cadherin switch underlies malignancy in high-grade gliomas. 2015, Pubmed